BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 9679158)

  • 1. Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.
    Herzberg IM; Trudeau MC; Robertson GA
    J Physiol; 1998 Aug; 511 ( Pt 1)(Pt 1):3-14. PubMed ID: 9679158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
    Chen J; Seebohm G; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12461-6. PubMed ID: 12209010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of dofetilide block of HERG K+ channels.
    Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
    Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
    Spector PS; Curran ME; Keating MT; Sanguinetti MC
    Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel.
    Fan JS; Jiang M; Dun W; McDonald TV; Tseng GN
    Biophys J; 1999 Jun; 76(6):3128-40. PubMed ID: 10354437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of amino-terminal distal and proximal domains in the regulation of human erg K(+) channel gating.
    Viloria CG; Barros F; Giráldez T; Gómez-Varela D; de la Peña P
    Biophys J; 2000 Jul; 79(1):231-46. PubMed ID: 10866950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.
    Ficker E; Jarolimek W; Brown AM
    Mol Pharmacol; 2001 Dec; 60(6):1343-8. PubMed ID: 11723241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of deactivation by an amino terminal domain in human ether-à-go-go-related gene potassium channels.
    Wang J; Trudeau MC; Zappia AM; Robertson GA
    J Gen Physiol; 1998 Nov; 112(5):637-47. PubMed ID: 9806971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the receptor site for ergtoxin, a specific blocker of ERG channels.
    Pardo-López L; García-Valdés J; Gurrola GB; Robertson GA; Possani LD
    FEBS Lett; 2002 Jan; 510(1-2):45-9. PubMed ID: 11755529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafast inactivation causes inward rectification in a voltage-gated K(+) channel from Caenorhabditis elegans.
    Fleischhauer R; Davis MW; Dzhura I; Neely A; Avery L; Joho RH
    J Neurosci; 2000 Jan; 20(2):511-20. PubMed ID: 10632580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of amino-terminal structures on kinetic transitions between several closed and open states in human erg K+ channels.
    Gómez-Varela D; de la Peña P; García J; Giráldez T; Barros F
    J Membr Biol; 2002 May; 187(2):117-33. PubMed ID: 12029369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
    Suessbrich H; Schönherr R; Heinemann SH; Lang F; Busch AE
    FEBS Lett; 1997 Sep; 414(2):435-8. PubMed ID: 9315735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
    Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
    Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
    Ficker E; Obejero-Paz CA; Zhao S; Brown AM
    J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open channel block of HERG K(+) channels by vesnarinone.
    Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
    Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
    Zhou Z; Gong Q; Ye B; Fan Z; Makielski JC; Robertson GA; January CT
    Biophys J; 1998 Jan; 74(1):230-41. PubMed ID: 9449325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes.
    Zou A; Curran ME; Keating MT; Sanguinetti MC
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1309-14. PubMed ID: 9087606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The eag family of K+ channels in Drosophila and mammals.
    Ganetzky B; Robertson GA; Wilson GF; Trudeau MC; Titus SA
    Ann N Y Acad Sci; 1999 Apr; 868():356-69. PubMed ID: 10414305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.